AzTrials
AzTrials

AgingEXI-AGENCT05571709

The Effect of Exercise on Myokine Production in Aging Persons

A study testing Exercise training, Questionnaire and Percutaneous muscle biopsy in people with Aging and Exercise, run by Hasselt University at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The incidence of age-related diseases, such as cancer and cardiovascular diseases, rapidly rises. These days, age-related diseases cause the majority of all healthcare expenses. During ageing senescent cells secrete a range of harmful inflammatory signals, which leads to chronic inflammation (inflamm-aging) and… Read more about this study

Who is it for?
Ages 65 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Aging, Exercise
What is being tested?
Exercise training, Questionnaire and Percutaneous muscle biopsy
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
1 siteBelgium
Study dates
15 Sep 2022to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Healthy persons

Who cannot join

  • Smoking
  • Infection < 2 weeks ago
  • Received a vaccine < 2 weeks ago
  • Allergy to Lidocain
  • Immune deficiency
  • Presence of a tumour or in treatment
Show all 12Show fewer
  • Usage of anti-coagulant medication
  • Presence of following conditions:
  • Haemophilia
  • Auto-immune disease
  • Cardiovascular disease
  • Musculoskeletal diseases which refrains the patient from exercising

Trial locations and contacts

1 site in 1 country.

Bert Op'T Eijnde, Prof. dr. contact

+3211292121

bert.opteijnde@uhasselt.be

Chiel Hex, MD. contact

chiel.hex@uhasselt.be

Belgium1 site, 1 recruiting
  • Hasselt University

    Diepenbeek, Limburg, 3590

    Lena Fonteyn, Drs., +3211269210, lena.fonteyn@uhasselt.be

    Leen Slaets, Dr., leen.slaets@uhasselt.be

    Recruiting

Other trials in Belgium

About this study

Official title: Does an Acute Exercise Bout Increases Soluble and Muscle Myokine Concentration in Healthy, Older Persons

The incidence of age-related diseases, such as cancer and cardiovascular diseases, rapidly rises. These days, age-related diseases cause the majority of all healthcare expenses. During ageing senescent cells secrete a range of harmful inflammatory signals, which leads to chronic inflammation (inflamm-aging) and accelerates aging throughout the rest of the body. Interestingly, people who regularly exercise show less signs of inflamm-aging compared to people with a sedentary lifestyle. Molecules secreted by skeletal muscles, called myokines, may play an important role. However, the underlying molecular mechanisms remain unknown. This pilot study aims to investigate if an acute bout of resistance training is an appropriate tool to induce an increase in the release of muscle derived myokines in aged persons.

Conditions
Aging, Exercise
Being tested
Exercise training, Questionnaire, Percutaneous muscle biopsy, Blood sample
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise trainingOther

    Resistance training of the lower limbs

  • QuestionnaireBehavioural

    Physical activity questionnaire

  • Percutaneous muscle biopsyProcedure or surgery

    Muscle biopsy of the vastus lateralis (m. quadriceps)

  • Blood sampleProcedure or surgery

    Venous blood sample

Study groups in NCT05571709
Study groupRoleWhat they receive
Aged individuals who perform exercise trainingActive comparatorAged individuals will perform an acute bout of resistance trainig (30 minutes). This training is focused on the lower limbs.
Receives: Other: Exercise training; Behavioral: Questionnaire; Procedure: Percutaneous muscle biopsy; Procedure: Blood sample
Aged individuals who stay sedentarySham comparatorAged individuals will remain seated for 30 minutes.
Receives: Behavioral: Questionnaire; Procedure: Percutaneous muscle biopsy; Procedure: Blood sample

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cytokine concentration

    Measurement of multiple cytokines in blood (for example: IL-6, IL-15, IL-4, irisin...) with ELISA's or multiplex assays

    Measured: Day 2

  2. Myokine production

    Immunohistochemistry staining (fluorescent) of multiple myokines (for example: IL-6, IL-15, IL-4, irisin..) and aging markers (p16,p21...) on muscle tissue

    Measured: Day 2

  3. Immune parameters

    Flow cytometry panels of immune parameters in muscle tissue

    Measured: Day 2

  4. Myokine protein levels

    Western blotting of multiple myokines in muscle tissue

    Measured: Day 2

  5. Myokine gene expression

    Quantitative PCR (polymerase chain reaction) of markers in muscle tissue

    Measured: Day 2

Secondary outcomes (3)
  1. Blood pressure

    The force of circulating blood on the walls of the arteries. Measured using an electronic sphygmomanometer

    Measured: Day 1

  2. Resting Heart Rate

    Measured using an electronic sphygmomanometer

    Measured: Day 1

  3. International Physical Activity Questionnaire (Short form)

    Measures the subjective level of activity of the last seven days. 7 questions regarding amount of time spent on certain activities.

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Oct 2022
  2. Study start15 Sep 2022
  3. Primary completion15 Oct 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
Aged individuals who perform exercise training are compared to aged individuals who remain sedentary.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05571709
Sponsor's protocol ID
B1152022000006
Acronym
EXI-AGE
Status last verified
Mar 2023
First submitted
5 Oct 2022
Last updated
31 Mar 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Exercise training, Questionnaire and Percutaneous muscle biopsy in people with Aging and Exercise, run by Hasselt University at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Bert Op'T Eijnde, Prof. dr. (+3211292121, bert.opteijnde@uhasselt.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cytokine concentration (time frame: Day 2). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in